ZA935154B - Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions - Google Patents

Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions

Info

Publication number: ZA935154B
Authority: ZA; South Africa
Prior art keywords: oxadiazole; oxides; treatment; erectile dysfunctions; dysfunctions
Prior art date: 1992-07-20

Application number

ZA935154A

Inventor

Karl Schoenafinger

Joachim Brendel

Christian Stief

Original Assignee

Cassella Farbwerke Mainkur Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-20

Filing date

1993-07-16

Publication date

1994-02-08

1993-07-16 Application filed by Cassella Farbwerke Mainkur Ag filed Critical Cassella Farbwerke Mainkur Ag

1994-02-08 Publication of ZA935154B publication Critical patent/ZA935154B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

ZA935154A 1992-07-20 1993-07-16 Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions ZA935154B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4223800A DE4223800A1 (en)	1992-07-20	1992-07-20	Use of 1.2.5-oxadiazole-2-oxides for the treatment of erectile dysfunctions

Publications (1)

Publication Number	Publication Date
ZA935154B true ZA935154B (en)	1994-02-08

Family

ID=6463617

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA935154A ZA935154B (en)	1992-07-20	1993-07-16	Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions

Country Status (7)

Country	Link
EP (1)	EP0581062A1 (en)
JP (1)	JPH06179620A (en)
KR (1)	KR940001890A (en)
CA (1)	CA2100830A1 (en)
DE (1)	DE4223800A1 (en)
HU (1)	HU9302060D0 (en)
ZA (1)	ZA935154B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4401150A1 (en) *	1994-01-17	1995-07-20	Cassella Ag	Furazancarbonsäurederivate
US5792758A (en) *	1995-12-08	1998-08-11	G. D. Searle & Co.	Steroid nitrite ester derivatives useful as anti-inflammatory drugs
US5985862A (en) *	1996-05-02	1999-11-16	G.D. Searle & Co.	Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
US5837698A (en) *	1996-05-02	1998-11-17	G. D. Searle & Co.	Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
DE19728103A1 (en) *	1997-07-02	1999-01-07	Winfried Dr Med Heinicke	Composition for treatment of erectile dysfunction
KR20020020536A (en) *	2000-09-09	2002-03-15	장우영	Injection for impotency
US7838023B2 (en)	2005-11-16	2010-11-23	Nitromed, Inc.	Furoxan compounds, compositions and methods of use
US8822509B2 (en)	2006-12-29	2014-09-02	The University Of Queensland	Pain-relieving compositions and uses therefor
AU2009266408C1 (en) *	2008-07-02	2015-12-10	The University Of Queensland	Pain-relieving compositions of furoxan NO donors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3012862A1 (en) *	1980-04-02	1981-10-08	Cassella Ag, 6000 Frankfurt	SUBSTITUTED 1,2,5-OXDIAZOLE-2-OXIDES AS PHARMACEUTICAL ACTIVE SUBSTANCES, THEIR USE AND MEDICINAL PRODUCTS CONTAINING THEM
DE3047730A1 (en) *	1980-12-18	1982-07-15	Cassella Ag, 6000 Frankfurt	3,4-SUBSTITUTED 1,2,5-OXDIAZOLE-2-OXIDES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
DE3047749A1 (en) *	1980-12-18	1982-07-22	Cassella Ag, 6000 Frankfurt	3,4-DISUBSTITUTED 1,2,5-OXDIAZOLE-2-OXIDES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
IT1252603B (en) *	1990-04-19	1995-06-19	Giorgio Cavallini	2,4-DIAMINO-6 PIPERIDINO PIRIMIDINA-3 TOPICAL OXIDE ON THE GLAND IN THE TREATMENT OF ERECTILE IMPOTENCES
EP0459666B1 (en) *	1990-05-31	1994-11-09	Pfizer Inc.	Medicaments against impotence

1992
- 1992-07-20 DE DE4223800A patent/DE4223800A1/en not_active Withdrawn
1993
- 1993-06-23 JP JP5152484A patent/JPH06179620A/en not_active Withdrawn
- 1993-07-06 EP EP93110752A patent/EP0581062A1/en not_active Withdrawn
- 1993-07-16 ZA ZA935154A patent/ZA935154B/en unknown
- 1993-07-16 HU HU9302060A patent/HU9302060D0/en unknown
- 1993-07-19 KR KR1019930013530A patent/KR940001890A/en not_active Application Discontinuation
- 1993-07-19 CA CA002100830A patent/CA2100830A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE4223800A1 (en)	1994-01-27
CA2100830A1 (en)	1994-01-21
JPH06179620A (en)	1994-06-28
KR940001890A (en)	1994-02-16
EP0581062A1 (en)	1994-02-02
HU9302060D0 (en)	1993-10-28

Publication	Publication Date	Title
GB9208339D0 (en)	1992-06-03	Treatment composition
GB9215633D0 (en)	1992-09-09	Novel treatment
GB9226860D0 (en)	1993-02-17	Novel treatment
IL107003A0 (en)	1993-12-28	3,3'-disubstituted-1,3-dihydro-2h-pyrrolo(2,3,-b)heterocyclic-2-one useful in the treatment of cognitive disorders of man
GB9203039D0 (en)	1992-03-25	Treatment
GB9211148D0 (en)	1992-07-08	Novel treatment
ZA935154B (en)	1994-02-08	Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions
GB9225860D0 (en)	1993-02-03	Novel treatment
GB9226957D0 (en)	1993-02-17	Novel treatment
GB9226958D0 (en)	1993-02-17	Produktionsaktieselskab) novel treatment
ZA933376B (en)	1995-02-14	Novel treatment
GB9203637D0 (en)	1992-04-08	Novel treatment
GB9225859D0 (en)	1993-02-03	Novel treatment
IL101630A0 (en)	1992-12-30	Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
GB9210596D0 (en)	1992-07-01	Treatment
GB9215903D0 (en)	1992-09-09	Treatment
GB9200359D0 (en)	1992-02-26	Treatment
GB9200360D0 (en)	1992-02-26	Treatment
GB9200361D0 (en)	1992-02-26	Treatment
GB9203249D0 (en)	1992-04-01	Treatment
GB9206395D0 (en)	1992-05-06	Treatment
GB9225948D0 (en)	1993-02-03	Novel treatment
AP9200456A0 (en)	1993-01-31	Novel treatment
GB9225959D0 (en)	1993-02-03	Novel treatment
GB9225961D0 (en)	1993-02-03	Novel treatment